The array, from Precision Neuroscience Corporation, is a core component of the company’s fully implantable, wireless brain-computer interface (BCI) system, which is currently in development.

A cellular mechanism was identified that prevents harmful TDP-43 protein aggregation in ALS by linking TDP-43 with SUMO, directing it to nuclear bodies for repair or degradation.